← All trials
NCT06780137
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 1, 2025
- Primary completion
- Oct 31, 2028
- Completion date
- Oct 31, 2028
- First posted
- Jan 17, 2025
- Last posted
- Feb 21, 2025
- Enrollment
- 138
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- MerckLead sponsor
- MerckOfficial
- Daiichi SankyoCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.